跳转至内容
Merck
CN

ZRB3110

Anti-LATS2 Antibody, clone 1L5 ZooMAb® Rabbit Monoclonal

newenhanced validation

recombinant, expressed in HEK 293 cells

别名:

EC:2.7.11.1, Kinase phosphorylated during mitosis protein, Large tumor suppressor homolog 2, Serine/threonine-protein kinase LATS2, Serine/threonine-protein kinase kpm, Warts-like kinase

登录查看公司和协议定价

选择尺寸


关于此项目

UNSPSC代码:
12352203
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

生物来源

rabbit

质量水平

重组

expressed in HEK 293 cells

偶联物

unconjugated

抗体形式

purified antibody

抗体产品类型

primary antibodies

克隆

1L5, recombinant monoclonal

描述

recombinant, expressed in HEK 293 cells

产品线

ZooMAb® learn more

表单

lyophilized

分子量

calculated mol wt 120.14 kDa
observed mol wt ~120 kDa

纯化方式

using Protein A

种属反应性

human

包装

antibody small pack of 25

增强验证

recombinant expression
Learn more about Antibody Enhanced Validation

技术

affinity binding assay: suitable
western blot: suitable

同位素/亚型

IgG

表位序列

Internal

Protein ID登记号

UniProt登记号

运输

ambient

储存温度

2-8°C

基因信息

human ... LATS2(26524)

一般描述

Serine/threonine-protein kinase LATS2 (UniProt: Q9NRM7; also known as EC:2.7.11.1 , Kinase phosphorylated during mitosis protein, Large tumor suppressor homolog 2, Serine/threonine-protein kinase kpm, Warts-like kinase) is encoded by the LATS2 (also known as KPM) gene (Gene ID: 26524) in human. LATS2 (Large Tumor Suppressor Kinase 2) is a serine/threonine kinase and a crucial component of the Hippo signaling pathway. LATS2 acts as a tumor suppressor by phosphorylating and inhibiting the transcriptional coactivators YAP and TAZ, thus regulating cell proliferation, apoptosis, and organ size. LATS2 is ubiquitously expressed across various tissues, with prominent expression in epithelial cells, and localizes predominantly to the cytoplasm and nucleus, where it forms condensates to facilitate Hippo pathway signaling and protein stabilization. It interacts with multiple proteins, including NF2 (Merlin), PRC2 (Polycomb Repressive Complex 2), and SREBP2, modulating diverse cellular processes such as epigenetic regulation, cholesterol homeostasis, and cytoskeletal dynamics. Dysregulation of LATS2 contributes to tumorigenesis and cancer progression, notably in breast cancer, lung cancer, and hepatocellular carcinoma. This ZooMAb® recombinant monoclonal antibody, generated by our proprietary technology, offers significantly enhanced specificity, affinity, reproducibility, and stability over conventional monoclonals. (Ref.: Sadaf, Zafar, M. et al., (2024), Sci Rep, 14, 28857; Han, H., et al., (2022), Nat Cell Biol 24, 74 87)
ZooMAb® antibodies represent an entirely new generation of recombinant monoclonal antibodies. Each ZooMAb® antibody is manufactured using our proprietary recombinant expression system, purified to homogeneity, and precisely dispensed to produce robust and highly reproducible lot-to-lot consistency. Only top-performing clones are released for use by researchers. Each antibody is validated for high specificity and affinity across multiple applications, including its most commonly used application. ZooMAb® antibodies are reliably available and ready to ship when you need them.

免疫原

KLH-conjugated linear peptide corresponding to 25 amino acids from the internal region of human LATS2.

应用

Quality Control Testing

Evaluated by Western Blotting in HEK-293 cell lysate.

Western Blotting Analysis: A 1:10,000 dilution of this antibody detected LATS2 in HEK-293 cell lysate.

Tested Applications

Western Blotting Analysis: A 1:1,000 dilution from a representative lot detected LATS2 in MCF7 cell lysate.

Affinity Binding Assay: A representative lot of this antibody bound with LATS2 peptide with at least one thousand-fold (1,000X) higher affinity than with non-specific control peptide.

Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user.

生化/生理作用

Clone 1L5 is a ZooMAb® rabbit recombinant monoclonal antibody that detects LATS2. It targets an epitope within 25 amino acids from the internal region.

外形

Purified recombinant rabbit monoclonal antibody IgG, lyophilized in PBS with 5% Trehalose, normal appearance a coarse or translucent resin. The PBS/trehalose components in the ZooMAb formulation can have the appearance of a semi-solid (bead like gel) after lyophilization. This is a normal phenomenon. Please follow the recommended reconstitution procedure in the data sheet to dissolve the semi-solid, bead-like, gel-appearing material. The resulting antibody solution is completely stable and functional as proven by full functional testing. Contains no biocide or preservatives, such as azide, or any animal by-products. Larger pack sizes provided as multiples of 25 µL.

制备说明

300 µg/mL after reconstitution at 25 µL per vial. Please refer to guidance on suggested starting dilutions and/or titers per application and sample type.
Recommend storage of lyophilized product at 2-8°C; Before reconstitution, micro-centrifuge vials briefly to spin down material to bottom of the vial; Reconstitute each vial by adding 25 µL of filtered lab grade water or PBS; Reconstituted antibodies can be stored at 2-8°C, or -20°C for long term storage. Avoid repeated freeze-thaws.

法律信息

ZooMAb is a registered trademark of Merck KGaA, Darmstadt, Germany

免责声明

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

未找到合适的产品?  

试试我们的产品选型工具.

法规信息

新产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持